Kraig Labs will address the commercial potential of genetically engineered spider silk at a November industry conference in ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's”), a world leader in spider silk technology*, today announced that Jon Rice, the Company’s Chief Operating ...

Presentation will feature new preclinical data of CPTx’s proprietary immune-quiet DNA vector delivered non-virally with targeting lipid ...

Spread the love“`html Imagine a future where your illness isn’t just treated, but cured by a microscopic agent designed ...

Precisely what is “precision fermentation”? The terminology itself deserves attention and you know I have opined about the co ...

Cinematic storytelling has increasingly embraced the post-credits stinger as an industry staple, conditioning moviegoers to linger in auditoriums until the ...

CHARLESTOWN, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company ...

A sold-out Kyoto symposium brought together scientists, clinicians, and innovators reviewing 20 years of iPSC research across development models, disease modeling, genetic stability, and clinical ...

A new Nature Chemical Engineering review maps how synthetic biology and stimuli-responsive materials are converging to embed ...

Five years ago, the Taliban barred Afghan girls from getting an education. In a residential neighborhood in Rwanda, some are ...

Spread the love“`html Imagine a world where a single treatment could potentially cure a debilitating chronic illness, not ...

Attractive biodistribution supports selection of MP0730 as Radio-DARPin therapy candidate ; CD70 is a clinically validated target expressed in kidney cancer and other indications; ...